Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Human Immunoglobulin For Intramuscular Injection (IMIG) market size was valued at US$ 965 million in 2024 and is forecast to a readjusted size of USD 1562 million by 2031 with a CAGR of 7.1% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Human immunoglobulin for intramuscular injection (IMIG), commonly known as 'IMIG', is an immunoglobulin preparation extracted and purified from healthy human plasma. It contains a variety of antibodies and is mainly used to enhance immunity. It is used by intramuscular injection and cannot be infused intravenously. Its functions include: 1. Prevention of infection: By providing antibodies against viruses (such as measles, hepatitis A, rubella, etc.) and bacteria, it helps prevent infections caused by these pathogens. 2. Replacement of xenogeneic blood products: Avoid the immune response caused by the use of animal blood products (such as horses, mice, etc.) to improve safety. 3. Treatment of immunodeficiency: Provide supplements for patients who cannot produce enough immunoglobulins on their own to help improve the function of the immune system.
This report is a detailed and comprehensive analysis for global Human Immunoglobulin For Intramuscular Injection (IMIG) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Immunoglobulin For Intramuscular Injection (IMIG) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Human Immunoglobulin For Intramuscular Injection (IMIG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Immunoglobulin For Intramuscular Injection (IMIG), with price, sales quantity, revenue, and global market share of Human Immunoglobulin For Intramuscular Injection (IMIG) from 2020 to 2025.
Chapter 3, the Human Immunoglobulin For Intramuscular Injection (IMIG) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Immunoglobulin For Intramuscular Injection (IMIG) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Immunoglobulin For Intramuscular Injection (IMIG) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Immunoglobulin For Intramuscular Injection (IMIG).
Chapter 14 and 15, to describe Human Immunoglobulin For Intramuscular Injection (IMIG) sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Human immunoglobulin for intramuscular injection (IMIG), commonly known as 'IMIG', is an immunoglobulin preparation extracted and purified from healthy human plasma. It contains a variety of antibodies and is mainly used to enhance immunity. It is used by intramuscular injection and cannot be infused intravenously. Its functions include: 1. Prevention of infection: By providing antibodies against viruses (such as measles, hepatitis A, rubella, etc.) and bacteria, it helps prevent infections caused by these pathogens. 2. Replacement of xenogeneic blood products: Avoid the immune response caused by the use of animal blood products (such as horses, mice, etc.) to improve safety. 3. Treatment of immunodeficiency: Provide supplements for patients who cannot produce enough immunoglobulins on their own to help improve the function of the immune system.
This report is a detailed and comprehensive analysis for global Human Immunoglobulin For Intramuscular Injection (IMIG) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Human Immunoglobulin For Intramuscular Injection (IMIG) market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Human Immunoglobulin For Intramuscular Injection (IMIG)
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Immunoglobulin For Intramuscular Injection (IMIG) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Children
- Adult
- Disease Prevention
- Treatment
- Diagnosis
- Other
- Grifols
- Pfizer
- Octapharma
- Takeda
- Kedrion Biopharma
- CSL Behring
- Tiantan Biological
- Hualan Biological
- Henjiu
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Human Immunoglobulin For Intramuscular Injection (IMIG) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Immunoglobulin For Intramuscular Injection (IMIG), with price, sales quantity, revenue, and global market share of Human Immunoglobulin For Intramuscular Injection (IMIG) from 2020 to 2025.
Chapter 3, the Human Immunoglobulin For Intramuscular Injection (IMIG) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Immunoglobulin For Intramuscular Injection (IMIG) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Immunoglobulin For Intramuscular Injection (IMIG) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Immunoglobulin For Intramuscular Injection (IMIG).
Chapter 14 and 15, to describe Human Immunoglobulin For Intramuscular Injection (IMIG) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Children
1.3.3 Adult
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Disease Prevention
1.4.3 Treatment
1.4.4 Diagnosis
1.4.5 Other
1.5 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size & Forecast
1.5.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (2020-2031)
1.5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.1.4 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Grifols Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.2.4 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Pfizer Recent Developments/Updates
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business
2.3.3 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.3.4 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Octapharma Recent Developments/Updates
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.4.4 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Takeda Recent Developments/Updates
2.5 Kedrion Biopharma
2.5.1 Kedrion Biopharma Details
2.5.2 Kedrion Biopharma Major Business
2.5.3 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.5.4 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Biopharma Recent Developments/Updates
2.6 CSL Behring
2.6.1 CSL Behring Details
2.6.2 CSL Behring Major Business
2.6.3 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.6.4 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 CSL Behring Recent Developments/Updates
2.7 Tiantan Biological
2.7.1 Tiantan Biological Details
2.7.2 Tiantan Biological Major Business
2.7.3 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.7.4 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Tiantan Biological Recent Developments/Updates
2.8 Hualan Biological
2.8.1 Hualan Biological Details
2.8.2 Hualan Biological Major Business
2.8.3 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.8.4 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Hualan Biological Recent Developments/Updates
2.9 Henjiu
2.9.1 Henjiu Details
2.9.2 Henjiu Major Business
2.9.3 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.9.4 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Henjiu Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN IMMUNOGLOBULIN FOR INTRAMUSCULAR INJECTION (IMIG) BY MANUFACTURER
3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Manufacturer (2020-2025)
3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Manufacturer (2020-2025)
3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Human Immunoglobulin For Intramuscular Injection (IMIG) by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer Market Share in 2024
3.4.3 Top 6 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer Market Share in 2024
3.5 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Overall Company Footprint Analysis
3.5.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Region Footprint
3.5.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Type Footprint
3.5.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Region
4.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2031)
4.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2031)
4.1.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Region (2020-2031)
4.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.4 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.5 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.6 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type (2020-2031)
5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
6.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application (2020-2031)
6.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
7.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
7.3 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
7.3.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
7.3.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
8.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
8.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
8.3.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
8.3.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Region
9.3.1 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
10.2 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
10.3 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
10.3.1 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
10.3.2 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
11.3.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Market Drivers
12.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Market Restraints
12.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Immunoglobulin For Intramuscular Injection (IMIG) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Immunoglobulin For Intramuscular Injection (IMIG)
13.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Distributors
14.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Children
1.3.3 Adult
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Disease Prevention
1.4.3 Treatment
1.4.4 Diagnosis
1.4.5 Other
1.5 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size & Forecast
1.5.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (2020-2031)
1.5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.1.4 Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Grifols Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.2.4 Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Pfizer Recent Developments/Updates
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business
2.3.3 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.3.4 Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Octapharma Recent Developments/Updates
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business
2.4.3 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.4.4 Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Takeda Recent Developments/Updates
2.5 Kedrion Biopharma
2.5.1 Kedrion Biopharma Details
2.5.2 Kedrion Biopharma Major Business
2.5.3 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.5.4 Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kedrion Biopharma Recent Developments/Updates
2.6 CSL Behring
2.6.1 CSL Behring Details
2.6.2 CSL Behring Major Business
2.6.3 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.6.4 CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 CSL Behring Recent Developments/Updates
2.7 Tiantan Biological
2.7.1 Tiantan Biological Details
2.7.2 Tiantan Biological Major Business
2.7.3 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.7.4 Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Tiantan Biological Recent Developments/Updates
2.8 Hualan Biological
2.8.1 Hualan Biological Details
2.8.2 Hualan Biological Major Business
2.8.3 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.8.4 Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Hualan Biological Recent Developments/Updates
2.9 Henjiu
2.9.1 Henjiu Details
2.9.2 Henjiu Major Business
2.9.3 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
2.9.4 Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Henjiu Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN IMMUNOGLOBULIN FOR INTRAMUSCULAR INJECTION (IMIG) BY MANUFACTURER
3.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Manufacturer (2020-2025)
3.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Manufacturer (2020-2025)
3.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Human Immunoglobulin For Intramuscular Injection (IMIG) by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer Market Share in 2024
3.4.3 Top 6 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer Market Share in 2024
3.5 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Overall Company Footprint Analysis
3.5.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Region Footprint
3.5.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Type Footprint
3.5.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Region
4.1.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2031)
4.1.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2031)
4.1.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Region (2020-2031)
4.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.4 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.5 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
4.6 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
5.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type (2020-2031)
5.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
6.2 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application (2020-2031)
6.3 Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
7.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
7.3 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
7.3.1 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
7.3.2 North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
8.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
8.3 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
8.3.1 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
8.3.2 Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Region
9.3.1 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
10.2 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
10.3 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
10.3.1 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
10.3.2 South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Market Size by Country
11.3.1 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Human Immunoglobulin For Intramuscular Injection (IMIG) Market Drivers
12.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Market Restraints
12.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Immunoglobulin For Intramuscular Injection (IMIG) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Immunoglobulin For Intramuscular Injection (IMIG)
13.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Distributors
14.3 Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 6. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Grifols Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 11. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Pfizer Recent Developments/Updates
Table 13. Octapharma Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma Major Business
Table 15. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 16. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Octapharma Recent Developments/Updates
Table 18. Takeda Basic Information, Manufacturing Base and Competitors
Table 19. Takeda Major Business
Table 20. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 21. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Takeda Recent Developments/Updates
Table 23. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Biopharma Major Business
Table 25. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 26. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Kedrion Biopharma Recent Developments/Updates
Table 28. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 29. CSL Behring Major Business
Table 30. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 31. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. CSL Behring Recent Developments/Updates
Table 33. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 34. Tiantan Biological Major Business
Table 35. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 36. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Tiantan Biological Recent Developments/Updates
Table 38. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Biological Major Business
Table 40. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 41. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Hualan Biological Recent Developments/Updates
Table 43. Henjiu Basic Information, Manufacturing Base and Competitors
Table 44. Henjiu Major Business
Table 45. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 46. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Henjiu Recent Developments/Updates
Table 48. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Manufacturer (2020-2025) & (K Dose)
Table 49. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Manufacturer (2020-2025) & (USD Million)
Table 50. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Manufacturer (2020-2025) & (US$/Dose)
Table 51. Market Position of Manufacturers in Human Immunoglobulin For Intramuscular Injection (IMIG), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 52. Head Office and Human Immunoglobulin For Intramuscular Injection (IMIG) Production Site of Key Manufacturer
Table 53. Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Type Footprint
Table 54. Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Application Footprint
Table 55. Human Immunoglobulin For Intramuscular Injection (IMIG) New Market Entrants and Barriers to Market Entry
Table 56. Human Immunoglobulin For Intramuscular Injection (IMIG) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 58. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2025) & (K Dose)
Table 59. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2026-2031) & (K Dose)
Table 60. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2025) & (USD Million)
Table 61. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2026-2031) & (USD Million)
Table 62. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Region (2020-2025) & (US$/Dose)
Table 63. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Region (2026-2031) & (US$/Dose)
Table 64. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 65. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 66. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type (2020-2025) & (USD Million)
Table 67. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type (2026-2031) & (USD Million)
Table 68. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2020-2025) & (US$/Dose)
Table 69. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2026-2031) & (US$/Dose)
Table 70. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 71. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 72. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application (2020-2025) & (USD Million)
Table 73. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application (2026-2031) & (USD Million)
Table 74. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2020-2025) & (US$/Dose)
Table 75. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2026-2031) & (US$/Dose)
Table 76. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 77. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 78. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 79. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 80. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 81. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 82. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 85. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 86. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 87. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 88. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 89. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 90. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 91. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 93. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 94. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 95. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 96. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2025) & (K Dose)
Table 97. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2026-2031) & (K Dose)
Table 98. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2025) & (USD Million)
Table 99. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2026-2031) & (USD Million)
Table 100. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 101. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 102. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 103. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 104. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 105. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 106. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 107. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 109. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 110. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 111. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 112. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 113. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 114. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 115. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 116. Human Immunoglobulin For Intramuscular Injection (IMIG) Raw Material
Table 117. Key Manufacturers of Human Immunoglobulin For Intramuscular Injection (IMIG) Raw Materials
Table 118. Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Distributors
Table 119. Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Customers
Table 1. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Grifols Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Major Business
Table 5. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 6. Grifols Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Grifols Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 11. Pfizer Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Pfizer Recent Developments/Updates
Table 13. Octapharma Basic Information, Manufacturing Base and Competitors
Table 14. Octapharma Major Business
Table 15. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 16. Octapharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Octapharma Recent Developments/Updates
Table 18. Takeda Basic Information, Manufacturing Base and Competitors
Table 19. Takeda Major Business
Table 20. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 21. Takeda Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Takeda Recent Developments/Updates
Table 23. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Biopharma Major Business
Table 25. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 26. Kedrion Biopharma Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Kedrion Biopharma Recent Developments/Updates
Table 28. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 29. CSL Behring Major Business
Table 30. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 31. CSL Behring Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. CSL Behring Recent Developments/Updates
Table 33. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 34. Tiantan Biological Major Business
Table 35. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 36. Tiantan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Tiantan Biological Recent Developments/Updates
Table 38. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Biological Major Business
Table 40. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 41. Hualan Biological Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Hualan Biological Recent Developments/Updates
Table 43. Henjiu Basic Information, Manufacturing Base and Competitors
Table 44. Henjiu Major Business
Table 45. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Product and Services
Table 46. Henjiu Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Henjiu Recent Developments/Updates
Table 48. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Manufacturer (2020-2025) & (K Dose)
Table 49. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Manufacturer (2020-2025) & (USD Million)
Table 50. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Manufacturer (2020-2025) & (US$/Dose)
Table 51. Market Position of Manufacturers in Human Immunoglobulin For Intramuscular Injection (IMIG), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 52. Head Office and Human Immunoglobulin For Intramuscular Injection (IMIG) Production Site of Key Manufacturer
Table 53. Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Type Footprint
Table 54. Human Immunoglobulin For Intramuscular Injection (IMIG) Market: Company Product Application Footprint
Table 55. Human Immunoglobulin For Intramuscular Injection (IMIG) New Market Entrants and Barriers to Market Entry
Table 56. Human Immunoglobulin For Intramuscular Injection (IMIG) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 58. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2025) & (K Dose)
Table 59. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2026-2031) & (K Dose)
Table 60. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2025) & (USD Million)
Table 61. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2026-2031) & (USD Million)
Table 62. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Region (2020-2025) & (US$/Dose)
Table 63. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Region (2026-2031) & (US$/Dose)
Table 64. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 65. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 66. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type (2020-2025) & (USD Million)
Table 67. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Type (2026-2031) & (USD Million)
Table 68. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2020-2025) & (US$/Dose)
Table 69. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2026-2031) & (US$/Dose)
Table 70. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 71. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 72. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application (2020-2025) & (USD Million)
Table 73. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application (2026-2031) & (USD Million)
Table 74. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2020-2025) & (US$/Dose)
Table 75. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2026-2031) & (US$/Dose)
Table 76. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 77. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 78. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 79. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 80. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 81. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 82. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 83. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 84. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 85. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 86. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 87. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 88. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 89. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 90. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 91. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 92. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 93. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 94. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 95. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 96. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2020-2025) & (K Dose)
Table 97. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Region (2026-2031) & (K Dose)
Table 98. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2020-2025) & (USD Million)
Table 99. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Region (2026-2031) & (USD Million)
Table 100. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 101. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 102. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 103. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 104. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 105. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 106. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 107. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 108. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2020-2025) & (K Dose)
Table 109. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Type (2026-2031) & (K Dose)
Table 110. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2020-2025) & (K Dose)
Table 111. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Application (2026-2031) & (K Dose)
Table 112. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2020-2025) & (K Dose)
Table 113. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity by Country (2026-2031) & (K Dose)
Table 114. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2020-2025) & (USD Million)
Table 115. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Country (2026-2031) & (USD Million)
Table 116. Human Immunoglobulin For Intramuscular Injection (IMIG) Raw Material
Table 117. Key Manufacturers of Human Immunoglobulin For Intramuscular Injection (IMIG) Raw Materials
Table 118. Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Distributors
Table 119. Human Immunoglobulin For Intramuscular Injection (IMIG) Typical Customers
LIST OF FIGURES
Figure 1. Human Immunoglobulin For Intramuscular Injection (IMIG) Picture
Figure 2. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type in 2024
Figure 4. Children Examples
Figure 5. Adult Examples
Figure 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application in 2024
Figure 8. Disease Prevention Examples
Figure 9. Treatment Examples
Figure 10. Diagnosis Examples
Figure 11. Other Examples
Figure 12. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (2020-2031) & (K Dose)
Figure 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price (2020-2031) & (US$/Dose)
Figure 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Human Immunoglobulin For Intramuscular Injection (IMIG) by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2020-2031) & (US$/Dose)
Figure 31. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2020-2031)
Figure 33. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2020-2031) & (US$/Dose)
Figure 34. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 46. France Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Region (2020-2031)
Figure 54. China Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 57. India Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 74. Human Immunoglobulin For Intramuscular Injection (IMIG) Market Drivers
Figure 75. Human Immunoglobulin For Intramuscular Injection (IMIG) Market Restraints
Figure 76. Human Immunoglobulin For Intramuscular Injection (IMIG) Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG) in 2024
Figure 79. Manufacturing Process Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 80. Human Immunoglobulin For Intramuscular Injection (IMIG) Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Human Immunoglobulin For Intramuscular Injection (IMIG) Picture
Figure 2. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Type in 2024
Figure 4. Children Examples
Figure 5. Adult Examples
Figure 6. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application in 2024
Figure 8. Disease Prevention Examples
Figure 9. Treatment Examples
Figure 10. Diagnosis Examples
Figure 11. Other Examples
Figure 12. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity (2020-2031) & (K Dose)
Figure 15. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Price (2020-2031) & (US$/Dose)
Figure 16. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Human Immunoglobulin For Intramuscular Injection (IMIG) by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Human Immunoglobulin For Intramuscular Injection (IMIG) Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Type (2020-2031) & (US$/Dose)
Figure 31. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Revenue Market Share by Application (2020-2031)
Figure 33. Global Human Immunoglobulin For Intramuscular Injection (IMIG) Average Price by Application (2020-2031) & (US$/Dose)
Figure 34. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 46. France Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Region (2020-2031)
Figure 54. China Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 57. India Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Human Immunoglobulin For Intramuscular Injection (IMIG) Consumption Value (2020-2031) & (USD Million)
Figure 74. Human Immunoglobulin For Intramuscular Injection (IMIG) Market Drivers
Figure 75. Human Immunoglobulin For Intramuscular Injection (IMIG) Market Restraints
Figure 76. Human Immunoglobulin For Intramuscular Injection (IMIG) Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG) in 2024
Figure 79. Manufacturing Process Analysis of Human Immunoglobulin For Intramuscular Injection (IMIG)
Figure 80. Human Immunoglobulin For Intramuscular Injection (IMIG) Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
